Hangzhou Testsea Biotechnology Co.,Ltd

Founded in 2015 with the pursuit for human and global health,Testsealabs Inc.creates innovative tech-nologies for the development of raw materials for diagnostic use.We offer diagnostic total solution such as rapid diaqnostic tests(RDTs),fluorescent immuno-diaqnostic tests, ELISA,molecular diagnostic tests(MDx)and clinical chemistry. We specialize in developing monoclonal antibodies and recombinant antigens in-house at our facility in China.We also have patented technoloqies includingfluorescentimmuno-diagnostics which will be one of the major IVD technologies of the future. Our facility is GMP,ISO9001and ISO13458 certified and we have CE FDA approval. Now we are looking forward to cooperating with more overseas companies for mutual development. Since its establishment,Testsealabs Inc has always insisted on R&D and innovation. At present, it has accumulated 1 software copyright and 50 authorized patents, including 4 invention patents, 46 new patents for use, and several special projects under application. Testsealabs Inc currently has more than 300 employees, an annual output of 300 million people, and a business area of 56,000 square meters. We pursuing the concept of "integrity, quality and responsibility", adhering to the tenet of quality first and serving the society, we constantly strive to develop new high-quality diagnostic raw materials, always adhere to the vision of serving the society and a healthy world, and are committed to promoting high-quality diagnostic products. Accurate diagnosis of all human diseases contributes to the cause of human health. Always find us here for solutions!